Presentation is loading. Please wait.

Presentation is loading. Please wait.

Laura Sarkisian, MD, Lotte Saaby, MD, PhD, Tina S

Published byGerd Ivarsson Modified over 6 years ago

Similar presentations

Presentation on theme: "Laura Sarkisian, MD, Lotte Saaby, MD, PhD, Tina S"— Presentation transcript:

1 Prognostic Impact of Myocardial Injury Related to Various Cardiac and Noncardiac Conditions 
Laura Sarkisian, MD, Lotte Saaby, MD, PhD, Tina S. Poulsen, MD, PhD, Oke Gerke, MSc, PhD, Susanne Hosbond, MD, PhD, Nikolaj Jangaard, BSc, Axel C.P. Diederichsen, MD, PhD, Kristian Thygesen, MD, DMSc, Hans Mickley, MD, DMSc  The American Journal of Medicine  Volume 129, Issue 5, Pages e1 (May 2016) DOI: /j.amjmed Copyright © 2016 Elsevier Inc. Terms and Conditions

2 Figure 1 Flow diagram illustrating the inclusion and classification of patients with myocardial injury. cTnI = cardiac troponin I; MI = myocardial infarction. The American Journal of Medicine  , e1DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

3 Figure 2 Kaplan-Meier survival curves in the 5 subgroups of patients with myocardial injury (unadjusted log-rank test; P <.0001). (A) Cardiac, secondary to ischemia; (B) Cardiac, not related to ischemia; (C) Noncardiac; (D) Multifactorial; (E) Indeterminate. The American Journal of Medicine  , e1DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions

Download ppt "Laura Sarkisian, MD, Lotte Saaby, MD, PhD, Tina S"

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,

Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,
Severe Tuberculosis Sepsis in an Immunocompetent Patient

Severe Tuberculosis Sepsis in an Immunocompetent Patient
The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest  Anders Morten Grejs, MD, Jakob.

The Extent of Myocardial Injury During Prolonged Targeted Temperature Management After Out-of-Hospital Cardiac Arrest  Anders Morten Grejs, MD, Jakob.
Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Axel.
Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?  Susanne Elisabeth Hosbond,

Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?  Susanne Elisabeth Hosbond,
Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.

Classification of Myocardial Infarction: Frequency and Features of Type 2 Myocardial Infarction  Lotte Saaby, MD, Tina Svenstrup Poulsen, MD, PhD, Susanne.
Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice  Nikolaj Jangaard, MD, Laura Sarkisian, MD, Lotte.

Incidence, Frequency, and Clinical Characteristics of Type 3 Myocardial Infarction in Clinical Practice  Nikolaj Jangaard, MD, Laura Sarkisian, MD, Lotte.
Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy  Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.

Effects of structured care by a pharmacist-diabetes specialist team in patients with Type 2 diabetic nephropathy  Wilson Y.S. Leung, BPharm, PhD, Wing-Yee.
Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C

Amay Parikh, MD, MBA, MS, Kunal Gupta, MD, MBA, Alan C
Laszlo Littmann, MD, PhD  The American Journal of Medicine 

Laszlo Littmann, MD, PhD  The American Journal of Medicine 
An Unusual Cause of Leg Ulcerations

An Unusual Cause of Leg Ulcerations
Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.

Impact of More Restrictive Blood Transfusion Strategies on Clinical Outcomes: A Meta- analysis and Systematic Review  Shelley R. Salpeter, MD, Jacob S.
Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction  Stein Ørn, MD, John G.F. Cleland, MD, Matti.
Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M

Matthew I. Worthley, MBBS, PhD, FRACP, Fiona M
Systematic Review of the Mediterranean Diet for Long-Term Weight Loss

Systematic Review of the Mediterranean Diet for Long-Term Weight Loss
Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study  Lars Frost, MD, PhD, Lone Juul Hune,
Prognostic Value of Low Blood Glucose at the Presentation of E

Prognostic Value of Low Blood Glucose at the Presentation of E

Similar presentations

Ads by Google